The pharmaceutical landscape has undergone a massive transformation with the emergence of new technologies, and cost-effective, and more efficient manufacturing approaches. Constant progress in personalized medicine has opened up numerous possibilities to target different health maladies and allowed the development of patient-centric models. This progress results in a shift from large batches to smaller batches for the development of complex medicines and autologous patient-centric treatments.
Market Size and Key Findings
The Global Pharmaceutical Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Pharmaceutical Market Size (In USD Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
A rise in drug approvals by regulatory bodies is expected to fuel drug manufacturing procedures. The growth in the approvals of pediatric medicine boosts the growth.
Competitive Landscape
Key Players
Major players in Pharmaceutical Market are F. Hoffmann-La Roche Ltd.; Novartis AG; GlaxoSmithKline plc; Pfizer, Inc.; Merck & Co., Inc.; AstraZeneca; Johnson & Johnson; Sanofi SA; Eli Lilly and Company; AbbVie, Inc.; Sun Pharmaceutical Industries Ltd.; Novo Nordisk A/S; Takeda Pharmaceuticals, Inc.; Cipla Limited; Bristol Myers Squibb Company; Gilead Sciences, Inc.
TABLE OF CONTENT
1. Report Description of the Global Pharmaceutical Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Pharmaceutical Market Executive Summary
2.1 Global Pharmaceutical Market– Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Pharmaceutical Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Pharmaceutical Market Segmentation
4.1 Molecule Type
4.1.1 Biological & Biosimilars (large molecules)
4.1.2 Conventional drugs (small molecules)
4.2 Drug development type
4.2.1 In-house
4.2.2 Outsource
4.3 Formulation
4.3.1 Tablets
4.3.2 Capsules
4.3.3 Injectables
4.3.4 Sprays
4.3.5 Suspensions
4.3.6 Powders
4.3.7 Other Formulations
4.4 Route of administration
4.4.1 Oral
4.4.2 Topical
4.4.3 Parenteral
4.4.4 Inhalation
4.4.5 Others
4.5 Therapy area
4.5.1 Cardiovascular diseases (CVDs)
4.5.2 Pain
4.5.3 Diabetes
4.5.4 Cancer
4.5.5 Respiratory Disease
4.5.6 Others
4.6 Prescription
4.6.1 Prescription Medicines
4.6.2 OTC Medicines
4.7 Age group
4.7.1 Children & Adolescents
4.7.2 Adults
4.7.3 Geriatric
4.8 Sales Channel
4.8.1 Retail
4.8.2 Non-retail
5. Global Pharmaceutical Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Pharmaceutical Market
9. Factors Driving Future Growth
9.1 New Trends & Development In Global Pharmaceutical Market
9.2 Future Opportunities
10. Strategic Recommendations
Segmentation
Pharmaceutical Market Segmentation
Molecule Type (Revenue, USD Billion):
In the pharmaceutical market, small molecule drugs account for the major part of the total global drug sales.
Biologics & Biosimilars (Large Molecules)
Conventional Drugs (Small Molecules)
Drug Development Type (Revenue, USD Billion):
Several benefits associated with outsourcing operations are expected to drive the segment growth at a lucrative pace over the coming years. Outsourced services minimize investments, reduce drug development & overall costs, increase the efficiency of manufacturing procedures, and easily comply with different regulatory norms.
In-house
Outsource
Formulation (Revenue, USD Billion):
Tablets
Capsules
Injectable
Sprays
Suspensions
Powders
Other Formulations
Route of administration (Revenue, USD Billion):
Oral
Topical
Parenteral
Inhalations
Other Routes of Administration
Therapy area (Revenue, USD Billion):
Cardiovascular Diseases (CVDs)
Pain
Diabetes
Cancer
Respiratory Diseases
Other Diseases
Prescription (Revenue, USD Billion):
Prescription Medicines
OTC Medicines
Age group (Revenue, USD Billion):
Children & Adolescents
Adults
Geriatric
Sales Channel (Revenue, USD Billion):
Retail
Non-retail
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
